- Advertisement -

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

24 August 2021 — Inventia Life Science, together with BioLamina AB, a Swedish biotechnology company leading in matrix biology and cell culture-based research, have...

New drug shows promise for epilepsy patients with resistant seizures

In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them...

Chemically bonded Mn₀․₅Cd₀․₅S/BiOBr S-scheme photocatalyst with rich oxygen vacancies for improved photocatalytic decontamination performance

A challenge in promoting the industrial application of photocatalysis technology for environment remediation lies in the design of high-performance photocatalysts. These photocatalysts should be...

$1 million grant helping empower students to succeed in the ‘fourth...

Transformational changes are already underway in the manufacturing industry as technological advancements, such as artificial intelligence (AI) and smart devices from the “fourth industrial...

Ribociclib plus hormone therapy extends survival for patients with premenopausal advanced...

MD Anderson-led Phase III trial finds targeted therapy lowers risk of death, is well-tolerated Credit: MD Anderson Cancer Center

Researchers make breakthrough in fight against COVID-19

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers...

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...

more new items

CDMOs Expand and Build for Future Growth

The top contract development and manufacturing organizations (CDMOs) have been busy in recent months expanding their service offerings, building new facilities, and navigating how...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s...

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...